Ex vivo stimulation of PBMCs with tumor lysate or peptide pools performed approximately 4–6 weeks after ablation (relative to Day 0) can quantify the frequency and polyfunctionality (production of IFN-γ, TNF-α, IL-2) of tumor-reactive T cells [144]. Here, IL2 is linked to neoplasm.